BioSpace News Archive

Business

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

Science 37 Holdings, Inc. disclosed the latest enrollment figures resulting from its Metasite™ and Patient Recruitment partnership with a leading biotech company whose asthma drug is currently undergoing a Phase 3 clinical trial.

May 2, 2024
·
2 min read
Policy

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsKR-HT5 is based on Akoya’s PhenoImager® HT Platform

Akoya Biosciences, Inc., The Spatial Biology Company®, and Shanghai KR Pharmtech have jointly announced that KR-HT5, which Akoya Biosciences co-developed with Shanghai KR Pharmtech utilizing the PhenoImager HT technology as its foundation, has received premarket approval from China’s National Medical Products Administration to support next generation pathology clinical workflows.

May 2, 2024
·
4 min read
Business

PDS Biotech Appoints Stephan Toutain as Chief Operating Officer

PDS Biotechnology Corporation announced the appointment of Stephan Toutain, MS, MBA, as Chief Operating Officer, effective as of May 1, 2024.

May 2, 2024
·
8 min read
Business

Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary

Rentschler Biopharma SE announced that Patrick Cushing, Ph.D., has been promoted to Vice President Operations of Rentschler Biopharma, Inc., the company’s U.S. subsidiary, effective May 1, 2024.

May 2, 2024
·
4 min read
Pharm Country

PTC Therapeutics to Participate at Upcoming May 2024 Investor Conferences

PTC Therapeutics, Inc. announced that the company will present a company overview at the following conferences.

May 2, 2024
·
1 min read